Information for Academia

An antibody shouldn’t be one of the variables in your experiment. Whether it’s knowing starting dilutions, being confident in target specificity or reliable lot-to-lot consistency, CST rigorously tests every lot of every antibody– so you don’t have to. This means that you can count on one CST antibody to perform as expected and to be available throughout your research without fear of lot-to-lot inconsistency. Our academic customers count on us to reduce the risk of wasting time and samples on non-specific, insensitive antibodies, allowing the generation of publication-quality data faster.

In fact, an independent survey showed that CST is ranked highest by customers for both antibody specificity (performance validation) and sensitivity¹. We invite you to examine our antibody validation data to learn why CST has earned the trust of your colleagues.

Why should I trust CST?

• Our bench to yours: CST is a scientist-led, private company that invests heavily in research and development. Like you, our scientists have exacting standards, so our antibodies are as specific and sensitive as your research demands.
• In-house development: 99% of our portfolio of antibodies is developed in-house. That means 98% of our products can be on your bench the next day. It also means that ,we are able to provide knowledgeable support by production scientists, and reliable lot-to-consistency.
• Application validation: CST doesn’t stop validation testing at a clean western blot. Whether IF, Flow, ChIP, IHC or ELISA – if we say it’s approved for the application, then we have validated it! And if the application protocol needs to be optimized for that specific antibody, we have done that work too and will provide the details.
• Lot-to-lot consistency: Need to reserve a lot for a longitudinal experiment? Not a problem. Every lot is validated in biologically relevant systems by CST production scientists who understand which cell lines or tissues, growth factors, cytokines or chemical activators/inhibitors are appropriate for the specific target protein. From the first lot to the last, we measure and track antibody performance and stay current on how our customers are using our antibodies in experiments.

1. Biocompare 2013